Oncternal Therapeutics Inc. (ONCT) Earnings
|
Expand Research on ONCT
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -462.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/9/24 | Q124 | -$2.83 | $0.00 | -$2.83 | $570K | N/A | N/A |  | | Details | |
| 3/7/24 | Q423 | -$3.11 | -$0.16 | -$2.95 | $297K | $175K | N/A | | | Details | |
| 11/9/23 | Q323 | -$0.17 | -$0.15 | -$0.02 | $180K | $125K | N/A | | | Details | |
| 8/10/23 | Q223 | -$0.15 | -$0.16 | +$0.01 | $106K | $170.83K | N/A | | | Details | |
| 5/4/23 | Q123 | N/A | -$0.21 | N/A | N/A | $260K | N/A | N/A | N/A | ||
| 3/9/23 | Q422 | -$0.20 | -$0.21 | +$0.01 | $171K | $306.2K | N/A | | | Details | |
| 11/3/22 | Q322 | -$0.19 | -$0.24 | +$0.05 | $2.13M | $305.8K | N/A | | | Details | |
| 8/9/22 | Q222 | -$0.16 | -$0.23 | +$0.07 | $883K | $459K | N/A | | | Details |
